Workflow
Should Value Investors Buy Genpact (G) Stock?
GGenpact(G) ZACKS·2024-09-26 14:46

Core Insights - Genpact (G) is currently rated 2 (Buy) by Zacks and has an A grade for Value, indicating strong potential for value investors [2] - The stock is trading at a P/E ratio of 11.73, significantly lower than the industry average of 24.69, suggesting it may be undervalued [2] - Genpact's PEG ratio stands at 1.40, compared to the industry average of 2.66, indicating favorable earnings growth expectations relative to its price [2] - The P/CF ratio for Genpact is 9.43, well below the industry average of 16.54, further supporting the notion of undervaluation based on cash flow [3] Valuation Metrics - P/E Ratio: Genpact's current P/E is 11.73, with a historical range between 9.75 and 12.05 over the past year [2] - PEG Ratio: The stock's PEG ratio has fluctuated between 0.97 and 1.50, with a median of 1.34, indicating a reasonable valuation relative to growth [2] - P/CF Ratio: Genpact's P/CF has ranged from 7.46 to 13.18, with a median of 8.68, highlighting its attractive cash flow valuation [3] Investment Outlook - Genpact is positioned as one of the strongest value stocks in the market, supported by its favorable earnings outlook and valuation metrics [3]